Latest Articles

  • On this we agree: The value of healthy debate in medicine
    John D. Clough, MD
    Cleveland Clinic Journal of Medicine March 2000, 67 (3) 152;

    The debate on dyspepsia on page 214 illustrates the value of healthy controversy.

  • How new technology is changing mammography and breast cancer management
    Gilda Cardenosa, MD, MS, William A. Chilcote, MD, Mary A. Barry, RN, Christine A. Quinn, MD and Mary G. Foglietti, RN
    Cleveland Clinic Journal of Medicine March 2000, 67 (3) 191-202;

    Improved detection now allows a tailored approach to abnormal findings.

  • Where to draw the line using statins: Lessons from 4S to AFCAPS/TexCAPS
    Dennis L. Sprecher, MD
    Cleveland Clinic Journal of Medicine March 2000, 67 (3) 169-171;

    For patients at low risk, a treatment that is beneficial statistically may not be practical or economical. But how should this question be decided? And who should decide?

  • In preventive cardiology there is no ‘One True Thing’
    Fredric J. Pashkow, MD
    Cleveland Clinic Journal of Medicine March 2000, 67 (3) 159-162;

    In preventing coronary artery disease, the only approach that works is multifactorial, focusing on permanent changes in diet, exercise, and stress management.

  • Should everyone over age 75 take a multivitamin?
    Should everyone over age 75 take a multivitamin?
    Cindy Moore, MS, RD, LD, FADA
    Cleveland Clinic Journal of Medicine March 2000, 67 (3) 155-156;

    Many—perhaps most—seniors are at risk of malnutrition, but age should not be the sole criterion.

  • Is there an advantage to combination therapy with ACE inhibitors and angiotensin II-receptor blockers?
    Donald G. Vidt, MD
    Cleveland Clinic Journal of Medicine February 2000, 67 (2) 89-91;

    Theoretic reasons and small studies suggest the two types of drugs may be useful in combination, but a definitive answer awaits the results of larger studies.

  • Psoriasis: A clinical update on diagnosis and new therapies
    Charles Camisa, MD
    Cleveland Clinic Journal of Medicine February 2000, 67 (2) 105-119;

    A framework for recognizing the many forms of psoriasis and a logical approach to therapy, which now includes, in severe cases, powerful immunosuppressive drugs.

  • Glycoprotein Ilb/IIIa inhibitors in acute coronary syndromes
    Matthew T. Roe, MD, Shelly K. Sapp, MS and A. Michael Lincoff, MD
    Cleveland Clinic Journal of Medicine February 2000, 67 (2) 131-140;

    These potent antiplatelet agents constitute a breakthrough, hut questions remain about their safety, cost-effectiveness, and proper empiric use. With an illustration explaining the paradoxical prothrombotic effect of fibrinolytic drugs.

  • Brain metastases: Presentation, evaluation, and management
    Mark A. Chidel, MD, John H. Suh, MD and Gene H. Barnett, MD
    Cleveland Clinic Journal of Medicine February 2000, 67 (2) 120-127;

    Prompt diagnosis and treatment can prolong the patient’s life and improve the quality of his or her remaining days.

  • Are strict vegetarians at risk of vitamin B<sub>12</sub> deficiency?
    Are strict vegetarians at risk of vitamin B12 deficiency?
    Margareta Novy, MPH, RD, LD
    Cleveland Clinic Journal of Medicine February 2000, 67 (2) 87;

    Patients who avoid or limit animal products in their diets should be encouraged to take vitamin B12 supplements or eat fortified foods.

Pages